These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34887919)

  • 1. A Systematic Review and Network Meta-Analysis on the Efficacy of Medications in the Treatment of Chronic Idiopathic Constipation in Japan.
    Nakajima A; Shoji A; Kokubo K; Igarashi A
    Gastroenterol Res Pract; 2021; 2021():5534687. PubMed ID: 34887919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis.
    Nelson AD; Camilleri M; Chirapongsathorn S; Vijayvargiya P; Valentin N; Shin A; Erwin PJ; Wang Z; Murad MH
    Gut; 2017 Sep; 66(9):1611-1622. PubMed ID: 27287486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.
    Luthra P; Camilleri M; Burr NE; Quigley EMM; Black CJ; Ford AC
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):831-844. PubMed ID: 31474542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative profiles of lubiprostone, linaclotide, and elobixibat for chronic constipation: a systematic literature review with meta-analysis and number needed to treat/harm.
    Rao SS; Manabe N; Karasawa Y; Hasebe Y; Nozawa K; Nakajima A; Fukudo S
    BMC Gastroenterol; 2024 Jan; 24(1):12. PubMed ID: 38166671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review with meta-analysis: lubiprostone efficacy on the treatment of patients with constipation.
    Passos MDCF; Takemoto MLS; Corradino GC; Guedes LS
    Arq Gastroenterol; 2020; 57(4):498-506. PubMed ID: 33331483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis.
    Black CJ; Burr NE; Quigley EMM; Moayyedi P; Houghton LA; Ford AC
    Gastroenterology; 2018 Dec; 155(6):1753-1763. PubMed ID: 30144426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation.
    Fukudo S; Hongo M; Kaneko H; Takano M; Ueno R
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):294-301.e5. PubMed ID: 25158925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis.
    Ford AC; Suares NC
    Gut; 2011 Feb; 60(2):209-18. PubMed ID: 21205879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.
    Shah ED; Kim HM; Schoenfeld P
    Am J Gastroenterol; 2018 Mar; 113(3):329-338. PubMed ID: 29380823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Efficacy of Drugs for the Treatment of Chronic Constipation: Quantitative Information for Medication Guidelines.
    Zhang Y; Yin F; Xu L; Li YF; Chen JC; Liu HX; Zheng QS; Li LJ
    J Clin Gastroenterol; 2020; 54(10):e93-e102. PubMed ID: 31904680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
    Thomas RH; Luthin DR
    Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Li F; Fu T; Tong WD; Liu BH; Li CX; Gao Y; Wu JS; Wang XF; Zhang AP
    Mayo Clin Proc; 2016 Apr; 91(4):456-68. PubMed ID: 27046523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Comparison of Elobixibat and Lubiprostone Treatment in Patients with Chronic Constipation: A Propensity Score-Matched Analysis.
    Eguchi T; Yoshizaki T; Ikeoka S; Takagi M; Fujinami M; Matsuda T; Yamaguchi T; Nonaka T; Amioka S; Katayama N; Inoue K; Matsumoto M; Momose K; Sako T; Noda M; Morisawa T; Okada A
    Dig Dis; 2021; 39(4):341-350. PubMed ID: 33142288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Lubiprostone in Patients with Opioid-Induced Constipation: Phase 3 Study Results and Pooled Analysis of the Effect of Concomitant Methadone Use on Clinical Outcomes.
    Spierings ELH; Drossman DA; Cryer B; Mazen Jamal M; Losch-Beridon T; Mareya SM; Wang M
    Pain Med; 2018 Jun; 19(6):1184-1194. PubMed ID: 29016868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in efficacy and safety of lubiprostone used for idiopathic vs opioid-induced constipation: meta-analysis of East Asian and Western populations.
    Sugimoto M; Murata M; Mizuno H
    J Clin Biochem Nutr; 2020 May; 66(3):184-192. PubMed ID: 32523244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Elobixibat in Patients with Diabetes and Concomitant Chronic Constipation: an 8-week, Prospective, Single-center, Single-arm Study.
    Hishida Y; Nagai Y; Tsukiyama H; Nakamura Y; Nakagawa T; Ishizaki S; Tanaka Y; Sone M
    Adv Ther; 2022 Sep; 39(9):4205-4217. PubMed ID: 35867276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Evaluation of Linaclotide for the Treatment of Adult Patients With Chronic Idiopathic Constipation in the United States.
    Huang H; Taylor DC; Carson RT; Sarocco P; Friedman M; Munsell M; Blum SI; Menzin J
    Manag Care; 2016 Feb; 25(2):41-8. PubMed ID: 27008836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of elobixibat and lubiprostone in Japanese patients with chronic constipation: a retrospective cohort study.
    Ooba N; Takahashi Y; Nagamura M; Takahashi M; Ushida M; Kawakami E; Kimura M; Sato T; Tokuyoshi J; Miyazaki C; Shimada M
    Expert Opin Drug Saf; 2021 Dec; 20(12):1553-1558. PubMed ID: 34281471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.
    Nakajima A; Seki M; Taniguchi S; Ohta A; Gillberg PG; Mattsson JP; Camilleri M
    Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):537-547. PubMed ID: 29805116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.